MATICA REPORTS ON RECENT MARKET ACTIVITY

November 21, 2017 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) at the request of the Investment Industry Regulatory Organization of Canada, management is pleased to provide an update on Company activities.

On November 11, 2017, 50,306,000 shares from the July 2017 five cent ($0.05) private placement (see NR July 10, 2017) were released for trading.  The introduction of the newly trading shares appears to have been the catalyst for an increase in the trading volume of Matica stock and an increase in the share price.  

Matica is currently completing construction of its Dorval medical cannabis facility.  Recently, the facility passed mechanical inspections.  Safety equipment, CO2 delivery, water and automated plant nutrition systems have all been installed.  Currently, the interior walls systems are being enclosed.  Matica is nearing the end of the construction phase at Dorval and we are in receipt of the Health Canada Guidelines for the Submission of Photographic-Evidence Licensing. Once the facility is completed we will be submitting the Photographic-Evidence video to Health Canada to request our cultivation license.

Late last week, Matica invited a third party investment group to film a video of Matica’s progress at the Dorval facility.  The video was shot at no charge to Matica and showcased the current progress at the facility. Please follow the link at FT Investment Club to view the video.

On September 27, 2017, Matica announced signing a non-binding letter of intent for Matica to become a majority owner of a late stage application under the Access To Cannabis for Medical Purposes Regulation (“ACMPR”) in southwestern Ontario. We are continuing our due diligence on the project. The application is for a 13,000 square foot building which could be easily expanded to 24,000 square feet by extending it to an adjoining building. The project sits on 14 acres of largely vacant land. Matica is contemplating building a 400,000 square foot facility on the property at a later date. Furthermore, Matica has negotiated a favourable purchase option for the entire property.  

 

For more information on Matica please visit the website at: www.maticaenterprises.com.

 

On behalf of the Board of Directors

MATICA ENTERPRISES INC.

 

/s/Boris Ziger

Boris Ziger, CEO & Chairman

 

The Company’s filings are available for review at www.sedar.com and www.thecse.com.

For further information, please contact Boris Ziger, Chief Executive Officer, at:

Telephone: 416-304-9935

E-mail: info@maticaenterprises.com

Website: www.maticaenterprises.com

 

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.

The CSE has not reviewed, approved or disapproved the content of this press release.

Recent News
ROYALMAX RECEIVES UPDATED CULTIVATION LICENCE AND COMPLETES MIGRATION TO THE NEW CANNABIS ACT
MATICA AND YUNIFY DEVELOP FIRST NEW CONSUMER PRODUCT
MATICA PROVIDES AN UPDATE ON THE VALUE OF SETTLEMENT SHARES
MATICA RECEIVES CULTIVATION LICENCE FOR DORVAL FACILITY
MATICA RECOIT UNE LICENCE DE CULTIVATION POUR L'INSTALLATION À DORVAL
MATICA ANNOUNCES $20,000,000 FINANCING WITH NEW YORK BASED ALUMINA PARTNERS
View All News…
Matica Quickform